GRANULES INDIA
Back to Balance Sheet
|
GRANULES INDIA Last 5 Year Total Liabilities History
[Consolidated]
| Mar2026 | Mar2025 | Mar2024 | Mar2023 | Mar2022 | |
|---|---|---|---|---|---|
| Total Liabilities | ₹7,656 Cr | ₹6,185 Cr | ₹5,484 Cr | ₹4,903 Cr | ₹4,512 Cr |
What is the latest Total Liabilities ratio of GRANULES INDIA ?
| Year | Total Liabilities |
|---|---|
| Mar2026 | ₹7,656 Cr |
| Mar2025 | ₹6,185 Cr |
| Mar2024 | ₹5,484 Cr |
| Mar2023 | ₹4,903 Cr |
| Mar2022 | ₹4,512 Cr |
How is Total Liabilities of GRANULES INDIA Trending?
| Years | Total Liabilities | % Change | |
|---|---|---|---|
| Mar2026 | ₹7,656 Cr | 23.79 | |
| Mar2025 | ₹6,185 Cr | 12.78 | |
| Mar2024 | ₹5,484 Cr | 11.84 | |
| Mar2023 | ₹4,903 Cr | 8.68 | |
| Mar2022 | ₹4,512 Cr | - | |
Compare Total Liabilities of peers of GRANULES INDIA
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| GRANULES INDIA | ₹22,525.1 Cr | 2.9% | -1.2% | 43.5% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹422,283.0 Cr | 0.1% | -5% | 5.4% | Stock Analytics | |
| DIVIS LABORATORIES | ₹244,762.0 Cr | -1.7% | 0.2% | 39.5% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹173,448.0 Cr | -2.5% | -5.5% | 30.2% | Stock Analytics | |
| CIPLA | ₹107,043.0 Cr | 0.9% | -2.6% | -14.6% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹102,820.0 Cr | 0.1% | 7.6% | -3.5% | Stock Analytics | |
GRANULES INDIA Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| GRANULES INDIA | 2.9% |
-1.2% |
43.5% |
| SENSEX | 3.1% |
1% |
-9.1% |
You may also like the below Video Courses